DAC-CEL T3 UPTAKE— 510(k) K810212

Substantially Equivalent

Burroughs Wellcome Co.

FDA 510(k) clearance K810212 for DAC-CEL T3 UPTAKE, Substantially Equivalent on 1981-02-10. Applicant: Burroughs Wellcome Co..

Clearance details

Applicant: Burroughs Wellcome Co.
Product code: Code KHQ
Advisory panel: Clinical Chemistry
Date received: 1981-01-27
Decision date: 1981-02-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.